Heart Benefits of Semaglutide Beyond Weight Loss
Research shows that semaglutide, an obesity medication, offers significant heart protection even when weight loss is minimal.
A new analysis of the SELECT trial found that semaglutide reduced the risk of heart attacks and other major events in people with obesity and cardiovascular disease,
even when people hadn’t lost much weight at all.
The cardioprotective effects of semaglutide may be independent of weight loss, with
about a third of the benefit tied to fat loss, and the bulk stemming from other mechanisms.
- Semaglutide reduces heart attack risk
- Benefits extend beyond weight loss
- May change how semaglutide and similar GLP-1 drugs are used
Author's summary: Semaglutide offers heart benefits beyond weight loss.
More News
- Israeli colonists plow hundreds of dunums in preparation to seize lands west of Hebron
- Teeth-whitening brand approved by dentists is handing out free items
- 'A House Of Dynamite' Ending Explained – Can The U.S. Stop A Nuclear Missile? What Decision Does The President Make? | Trending News Buzz
- Israeli colonists fence off Palestinian lands in northern Jordan Valley in preparation for seizure
- Fond du Lac man arrested after domestic situation/stand off - KFIZ News-Talk 1450 AM
- Geothermal heat going mainstream in Toronto | Juggling Dynamite
- Israeli colonists cut down dozens of olive trees south of Bethlehem
- Gold and silver prices fall in domestic market following global decline
- The Conversation: Pumpkins’ journey from ancient food staple to spicy fall obsession spans thousands of years - NKyTribune
- Israeli Settlers Burn Palestinian Homes in Jerusalem; Attack Elders in Hebron